Brief: IX Biopharma posts quarterly loss of S$3.2 mln
08/11/2017 10:33
Nov 8 (Reuters) - IX Biopharma Ltd IXBI.SI
* Qtrly revenue S$1.7 million versus S$1.5 million
* Qtrly loss for financial period S$3.2 million versus loss
of
S$776,000
Source text for Eikon: urn:newsml:reuters.com:*:nSNZbRkw0t
Further company coverage: IXBI.SI
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine
Brief: IX Biopharma To Raise At Least S$6 MLN Via Placement At S$0.198 Per Share
Brief: IX Biopharma Enters Term Sheet For Proposed Joint Venture